<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200914048720N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-10-13</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Design and Effect of Biofeedback Model for Motor Rehabilitation</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effectiveness of a biofeedback-based rehabilitation model based on muscle synergy model in upper limb mobility in patients with cerebral palsy due to stroke</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-10-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>24</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/50944</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: For the first time, it covers the challenge between clinical research and the engineering aspects of making biofeedback programs and can lead to the development of an efficient, inexpensive, and telemedicine method of rehabilitation, Randomization description: In this study, we use simple randomization models such as a Heads or Tails, using a random number table or using computer randomization methods and the Python program, and each client, for example, by dropping coins, head and tail in We put the intervention or control group, Blinding description: This study was divided into control and intervention groups. In this study, patients in both groups were evaluated before the intervention using inclusion criteria and main tests.
Group 1: Regular physiotherapy exercises
Group 2: Regular physiotherapy exercises plus 30 minutes of biofeedback-based training (intervention on the affected hand).
The intervention is also performed as a double-blind randomized clinical trial. Blinding is for 3 groups of subjects, researchers and analysts.
In this study, the evaluators (specialist physician, occupational therapist, and medical engineer) will be completely blind to the type of intervention and the group, because the tests will be evaluated by another team that is familiar with these tools.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Hemiplegia due to ischemic stroke in the middle cerebral artery.</hc_freetext>
      <i_freetext>Intervention 1: Control group: Normal physiotherapy exercises Non-invasive movement exercises for adduction and abduction the arm. Intervention 2: Intervention group: In addition to the usual physiotherapy exercises, movement exercises such as adduction and abduction the arm based on visual feedback and biofeedback-based voice in 10 sessions for 30 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All information except recorded raw data will be shared from subjects after the defense and publication of articles.

When:
Access period starts 6 months after the publication of results and articles

To whom:
Students and researchers in the field of rehabilitation

Conditions:
Raw data is not available, but other results and documentation with reference to the source are not prohibited.

Where to obtain:
Seyyed Ali Zendehbad
ali.zendebad@gmail.com

How to obtain:
Only valid university email and send ID card photo

Comments:
Be steadfast and victorious</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Athena Sharifi Razavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Bu Ali Hospital (Avicenna Hospital),Pasdaran Boulevard, Sari, Mazandaran Province</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4815838477</zip>
        <telephone>+98 11 3334 3011</telephone>
        <email>athena.sharifi@yahoo.com</email>
        <affiliation>Mazandaran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyyed Ali Zendehbad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit Five, Shemiran Building, Shahid Moghadam Far Alley, Pasdaran Boulevard, Sari, Mazandaran</address>
        <city>Sari</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4814914711</zip>
        <telephone>+98 11 3334 7289</telephone>
        <email>ali.zendebad@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>These Subjects should be Healthy and have no myopathic or anatomical problems
Subjects  must be right-handed
subjects must not athletes
24 hours have passed since their stroke and they are in stable condition
Patients should be in the acute phase
The patients must  be middle cerebral artery ischemic cerebral palsy
Signing the patient's informed consent form</inclusion_criteria>
      <agemin>24 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Cognitive problem
Unstable clinical condition
Vision problem
hearing problem
They will not be able to record signals and cooperate in research in the day
Previous stroke history
Problem of myopathy before stroke
Hemorrhagic stroke
Chronic phase
Mental retardation</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G46.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Middle cerebral artery syndrome</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: Normal physiotherapy exercises Non-invasive movement exercises for adduction and abduction the arm</i_keyword>
      <i_keyword>Intervention group: In addition to the usual physiotherapy exercises, movement exercises such as adduction and abduction the arm based on visual feedback and biofeedback-based voice in 10 sessions for 30 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Surface electromyogram signal analysis and motion analysis and the score of two Fugl-Meyer and NHISS tests will be used. Timepoint: 1 day after stroke, before intervention, 10 sessions after intervention. Method of measurement: 4-channel surface electromyography; Webcam recording; Questionnaires and clinical tests by a neurologist and physiotherapist.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>N/A</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-09-25</approval_date>
        <contact_name>Ethics Committee of Mazandaran University of Medical Sciences</contact_name>
        <contact_address>Bu Ali Hospital (Avicenna Hospital),Pasdaran Boulevard, Sari, Mazandaran Province Sari Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
